Actions - Biotech
Retour aux Propensions des Marchés Actions
Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absolu | Relatif | |||||||||||||||||||
55 | Pluvalca Health Opport. A | 115.7 | +++ | +++++ | + | Neutre | ||||||||||||||
50 | Taux = + 15% | +++ | +++++ | |||||||||||||||||
14 | Tx ESTER j/j rate | + | ++ | |||||||||||||||||
11 | Swed. Orphan Bio | 275.2 | + | + | - | Neutre | Biotech | 26.2 X | 0.0% | ++ | +++ | + | ++++ | +++ | - | - | SOBI | MID | ||
0 | Taux ZERO | Neutre | Neutre | |||||||||||||||||
-20 | Candriam Eqties. L Biotech C | 829.1 | - | - | - - - | Neutre | ||||||||||||||
-36 | Franklin Biotech Discovery A | 40.40 | - - | - | - - - - | Neutre | ||||||||||||||
-49 | Genmab A/S | 1 965 | - - - | - - | - - - - | Neutre | Biotech | 30.0 X | 0.0% | + | +++++ | +++++ | ++++ | +++++ | GMA | BIG | ||||
-51 | Taux = - 5% | - - - | - - - | |||||||||||||||||
-69 | CS L Digital Health Eqt. B | 592.8 | - - - - | - - - | - - - - - | Neutre |